Molecular and Immunohistologic Analyses Cannot Reliably Solve Diagnostic Variation of Flat Intraepithelial Lesions of the Urinary Bladder

Murata, Shin-ichi; Iseki, Masachika; Kinjo, Mitsuru; Matsuzaki, Osamu; Moriuchi, Akira; Ohtani, Hiroshi; Sakurai, Takaki; Satake, Tatsunari; Tsuzuki, Toyonori
December 2010
American Journal of Clinical Pathology;Dec2010, Vol. 134 Issue 6, p862
Academic Journal
We examined diagnostic variation of flat intraurothelial lesions with comparison with immunohistochemical and fluorescence in situ hybridization (FISH) analyses. Nine uropathologists diagnosed 23 biopsy samples from the urinary bladder. The samples were analyzed by immunohistochemical expression of cytokeratin 20, high-molecular-weight cytokeratin, Ki-67, p53, and p16INK4a, and multicolor FISH using the UroVysion probe set (Vysis, Abbott, Des Plaines, IL). Diagnostic agreement for each classification and for nonneoplastic or neoplastic lesions was obtained in 8 (35%) and 16 (70%) of 23 lesions, respectively. The preference ratio of neoplasia to nonneoplasia (0.9 to 4.8) or carcinoma in situ to dysplasia (0.2 to 4.0) also varied among the pathologists. In 6 ancillary analyses, the majority of neoplastic lesions with diagnostic agreement indicated more than 2 aberrant results, whereas the majority of lesions without diagnostic agreement showed no or only 1 aberrant result. The molecular and immunohistochemical analyses can discriminate between neoplastic and nonneoplastic lesions; however, they cannot reliably solve diagnostic variation of flat intraepithelial lesions.


Related Articles

  • Immunohistochemical and in situ hybridization analysis of galectin-3, a β-galactoside binding lectin, in the urinary system of adult mice. Nio, Junko; Takahashi-Iwanaga, Hiromi; Morimatsu, Masami; Kon, Yasuhiro; Iwanaga, Toshihiko // Histochemistry & Cell Biology;Jul2006, Vol. 126 Issue 1, p45 

    Galectin is an animal lectin that has high affinity to β-galactoside of glycoconjugates. In the present study, cellular expression of galectin subtypes in the urinary system of adult mice was examined by in situ hybridization and immunohistochemistry. The major subtype expressed in the murine...

  • Automated analysis of protein expression and gene amplification within the same cells of paraffin-embedded tumour tissue. Gaiser, Timo; Berroa-Garcia, Lissa; Kemmerling, Ralf; Dutta, Aparajita; Ried, Thomas; Heselmeyer-Haddad, Kerstin // Cellular Oncology (2211-3428);Aug2011, Vol. 34 Issue 4, p337 

    Background: The simultaneous detection of protein expression and gene copy number changes in patient samples, like paraffin-embedded tissue sections, is challenging since the procedures of immunohistochemistry (IHC) and Fluorescence in situ Hybridization (FISH) negatively influence each other...

  • Molecular bone morphometry. Langub, M. C.; Faugere, M. C.; Malluche, H. H. // Pediatric Nephrology;Jul2000, Vol. 14 Issue 7, p629 

    Quantitative histomorphometric assessment of bone biopsies represents a powerful and informative method for the study of metabolic bone diseases. It is the gold standard against which the noninvasive ”diagnostic” markers of bone metabolism as well as newly available therapeutic...

  • TMA for all: a new method for the construction of tissue microarrays without recipient paraffin block using custom-built needles. Pires, Andréa Rodrigues Cordovil; da Matta Andreiuolo, Felipe; de Souza, Simone Rabello // Diagnostic Pathology;2006, Vol. 1, p14 

    Background: TMAs are becoming a useful tool for research and quality control methods, mostly for immunohistochemistry and in situ hybridization. Methods: A new technique that allows building TMA blocks with more than 300 tissue cores without using a recipient paraffin block for the tissue cores...

  • Defective expression of FasL and Bax in human lung cancer. Herrera-Esparza, R.; Badillo-Almaraz, I.; Villalobos, R.; Avalos-Díaz, E.; Badillo-Salas, C. // Clinical & Experimental Medicine;Sep2003, Vol. 3 Issue 2, p106 

    The present studies investigated whether FasL and Bax genes are expressed in pleuro-pulmonary biopsies from patients with lung cancer. FasL, Bax, and TNFα mRNAs were detected in 19 biopsies of primary or metastasic lung cancer by fluorescent in situ hybridization assays. Fluorescent probes...

  • Synovial sarcoma of the larynx treated by supraglottic laryngectomy: Case report and literature review. Luna-Ortiz, Kuauhyama; Cano-Valdez, Ana María; da Cunha, Isabela Werneck; Mosqueda-Taylor, Adalberto // ENT: Ear, Nose & Throat Journal;Jul2013, Vol. 92 Issue 7, pE20 

    We describe a case of synovial sarcoma of the larynx, and we discuss the use of fluorescence in situ hybridization (FISH) in confirming the diagnosis. The patient was a 21-year-old woman who presented with a recurrence of a previously resected supraglottic tumor of the aryepiglottic folds. A...

  • How should HER2 status be determined? McNeil, Caroline // JNCI: Journal of the National Cancer Institute;01/20/99, Vol. 91 Issue 2, p111 

    Presents information on the determination of HER2 status on breast tumors. Advantages and disadvantages of immunohistochemistry and fluorescent in situ hybridization (FISH); HER2 tests approved by the United States Food and Drug Administration.

  • Local reaction to the different meshes at the vesicovaginal space in rabbit model. Zhang, Kun; Han, JinSong; Yao, Ying; Yang, Junfang; Qiao, Jie // International Urogynecology Journal;May2012, Vol. 23 Issue 5, p605 

    Introduction and hypothesis: This paper aims to study the vesicovaginal space local tissue reaction to type I and II polypropylene mesh in a rabbit model. Methods: Different types of meshes were implanted into the rabbit vesicovaginal space. The animals were killed at days 7 and 60, and the...

  • Her-2 neu (Cerb-B2) expression in fine needle aspiration samples of breast carcinoma: A pilot study comparing FISH, CISH and immunocytochemistry. KAPILA, KUSUM; AL-AWADHI, S.; FRANCIS, I. M. // Journal of Cytology;Apr-Jun2011, Vol. 28 Issue 2, p54 

    Background: Breast cancers with Her-2 neu gene amplification are recognized as important markers for aggressive disease and targets which respond to therapy with trastuzumab. Her-2 neu testing on histological sections is routinely performed to select patients who may benefit from anti- Her-2 neu...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics